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Abstract
Complete anesthesia is often described using terminology that pertains 
to the pharmacodynamic effects of the medications administered. This 
vocabulary often includes akinesia, analgesia, amnesia and hypnosis. Local 
anesthesia is more specific and represents the administration of an amide or 
ester local anesthetic, to affect analgesia, at or around the site of administra-
tion. Anesthesiologists employ a breadth of different clinical techniques that 
utilize local anesthetic medications. These techniques include topical, mucosal, 
endotracheal, intravenous, peripheral nerve block, epidural, and intrathecal 
(spinal) administration. Unique to the fields of anesthesiology and pain medi-
cine, however, is the administration of epidural and intrathecal local anesthetic. 
Together, these routes are jointly referred to as neuraxial anesthesia and are often 
utilized to facilitate surgical intervention, labor analgesia, or pain therapy. The 
history of neuraxial local anesthetic administration is rich and intriguing. The 
anatomy of the spinal cord and surrounding structures is complex and pertinent 
to the pharmacologic discussion of neuraxial local anesthetic administration. 
The pharmacodynamic and pharmacokinetic interactions of local anesthetics, 
when administered via the neuraxial route, are unique and worthy of continued 
investigation. Much has been studied, but there is still more to be discovered. 
These topics will be the focus of our discussion.
Keywords: anesthetics, local, anesthesia, conduction, pharmacology,  
administration and dosage pharmacokinetics, drug-related side effects and adverse 
reactions, injections, spinal, injections, epidural, epidural space, analgesia, epidural, 
anesthesia, epidural, ropivacaine, bupivacaine, lidocaine, chloroprocaine
1. Introduction
Anesthesia is often described using terminology that references the pharma-
codynamic effects of a medication. This terminology often includes akinesia (loss 
or impairment of voluntary movement), analgesia (insensibility to pain), amnesia 
(loss of memory) and hypnosis (any of various conditions that resemble sleep). 
Local anesthesia is more specific and represents the administration of a medica-
tion, typically an amide or ester local anesthetic, to affect analgesia, and possibly 
akinesia, at or around the site of administration. Anesthesiologists employ a 
breadth of different clinical techniques that utilize local anesthetic medications. 
These techniques include topical, mucosal, endotracheal, intravenous, peripheral 
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nerve block, epidural, and intrathecal (spinal) administration. Unique to the 
fields of anesthesiology and pain medicine, however, is the administration of 
local anesthetics via the epidural and intrathecal routes. Together, these routes 
are jointly referred to as neuraxial anesthesia and are often utilized to facilitate 
surgical intervention, labor analgesia, or pain therapy. Much has been studied, 
but there is still more to be discovered. These topics will be the focus of our 
discussion.
2. Neuraxial anesthesia
2.1 Basic anatomy
To understand the pharmacokinetic, pharmacodynamic, and pharmacothera-
peutic activity of local anesthetics in this region, one needs a thorough understand-
ing of neuraxial anatomy. The term neuraxis refers to the axial unpaired portion 
of the central nervous system. Of great importance to the discussion of neuraxial 
anesthesia is the spinal cord, nerve roots, and the meninges and vertebral bodies 
that house and protect them.
2.1.1 Membranes
The spinal cord is surrounded by three protective membranes which delineate 
potential and actual neuraxial spaces. Listed from outermost to innermost, these 
membranes are termed meninges and refer to the dura mater, the arachnoid mater 
and the pia mater. The pia mater directly envelops the spinal cord (Figure 1). 
Epidural refers to the potential space between the ligamentum flavum and the outer 
surface of the dura mater. Subdural refers to a potential space between the dura 
mater and the arachnoid mater. The term intrathecal refers to the thecal sac or the 
dura mater enclosure of the cerebrospinal fluid-filled sub-arachnoid (i.e., sub-
arachnoid mater) space. This space remains outside of the pia mater. These spaces 
are surrounded by the bony architecture created by the vertebrae.
Figure 1. 
Meninges—protective membranes of the spinal cord.
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2.1.2 Bones and ligaments
The vertebral column protects the spinal cord and provides support for standing 
and walking. The vertebral column is easily recognized by its three curvatures (cer-
vical lordosis, thoracic kyphosis, and lumbar lordosis) and five sections, to include 
the cervical, thoracic, lumbar, sacral and coccygeal regions. Each region consists 
of seven, twelve, five, five, and four vertebrae respectively for a total of 33. Each 
vertebra consists of two components: a vertebral body and the remaining vertebral 
arch. The vertebral arch is composed of several components to include laminae, 
pedicles, spinous, and transverse processes (Figure 2). Access to the epidural and 
intrathecal space for neuraxial local anesthetic administration is obtained via the 
spaces between each vertebra. Variation in bony structure between lumbar, tho-
racic, and cervical vertebrae will dictate the approach to these specific regions (e.g., 
the greater downward angle of the thoracic spinous processes necessitates a steeper 
midline approach). Between each of the vertebra are several ligaments that are also 
typically traversed when administering neuraxial local anesthetics. From superficial 
to deep are the supraspinous ligament, interspinous ligament, and the ligamentum 
flavum (named for its yellow pigmentation). The interspinous ligament is affixed 
to the inferior and superior aspect of the spinous processes. The supraspinous 
ligament attaches to the tips of the vertebral spinous processes (Figure 3) and runs 
from the level of C7 to the sacrum.
2.1.3 Vasculature/adipose tissue
The epidural space contains several anatomic structures and tissues to include 
vasculature, nerve roots, and adipose tissue. The internal vertebral venous plexus, 
also known as the epidural venous plexus, assists with vertebral venous drainage 
and serves as an alternate conduit for venous return in the setting of compro-
mised caval blood flow. The plexus consists of two larger anterior longitudinal 
veins, located in the anterior aspect of the spinal canal, and two smaller posterior 
longitudinal veins. These veins are connected by transverse veins, completing 
the plexus. The longitudinal veins are located more posteriorly at the level of the 
cervical and lumbar vertebrae, and more posterolaterally at the level of the thorax 
[1]. The plexus is surrounded by epidural adipose tissue. Combined with reported 
Figure 2. 
Human vertebral column and vertebrae. The human vertebral column consists of 33 vertebrae.
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disruptions in the posterior fusions of the left and right ligamentum flavum, the 
adipose tissue and vasculature serve to provide variation in the construct of this 
potential space when expanded by local anesthetic.
2.2 Intrathecal administration
2.2.1 History of spinal anesthesia
Various local anesthetics have been investigated for surgical anesthesia (Table 1). 
These are divided into two primary categories of local anesthetics (i.e., esters and 
amides). Initial studies began with the investigation of the spinal effects of esters 
such as cocaine. This was followed by investigation of amylocaine (no longer utilized 
in clinical practice), procaine (also known as Novocain), dibucaine and tetracaine. 
Of note, amylocaine was first synthesized circa 1903 and is referenced as the first 
synthetic local anesthetic to be utilized in spinal anesthesia [2]. This was followed 
by the synthesis of procaine (circa 1904) with subsequent early twentieth-century 
investigation into its intrathecal administration. Procaine likely found greater 
clinical application as a result of the presumed systemic effects (to include physical 
dependence) and presumed neurotoxic effects of spinal cocaine administration [3]. 
Of note, however, is the side effect profile of procaine, which commonly includes 
nausea, vasomotor paralysis, and a greater risk for anaphylaxis associated with its 
metabolite para-aminobenzoic acid (PABA) [3, 4]. The period of 1930 through the 
early 1940s saw the discovery and intrathecal employment of longer acting local 
anesthetics (i.e., dibucaine and tetracaine). In 1930, Jones described his experiences 
with the administration of dibucaine (also known as cinchocaine or nupercaine) 
[5, 6]. With a shorter duration of action compared to dibucaine, a more favorable 
ratio of sensory to motor fiber blockade, less sympathetic blockade than procaine, 
and less perceived toxicity, initial studies into the administration of tetracaine 
showed significant promise [7, 8]. In 1945, lidocaine (originally called Xylocaine 
as it is a xylidine derivative) was initially administered as a spinal anesthetic. As a 
Figure 3. 
Spinal ligaments—this file is licensed under the Creative Commons Public Domain Mark 1.0—https://
commons.wikimedia.org/wiki/File:Gray301.png.
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short-acting amide local anesthetic, its pharmacologic profile was deemed ideal for 
short to moderate duration operative procedures [9]. Subsequently, in 1946, procaine 
was used to synthesize chloroprocaine. Initial reports for the use of chloroprocaine 
for spinal anesthesia were positive [10], and chloroprocaine was approved for spinal 
anesthesia by the United States Food and Drug Administration in 1955. With rapid 
ester hydrolysis neutralizing the effects of chloroprocaine, it became the local 
anesthetic of choice for the fastest onset and fastest resolution of spinal blockade. 
The rapid ester hydrolysis also created an environment in which almost twice the 
amount of chloroprocaine could be administered, compared to procaine, without 
toxicity. The improved safety profile also likely contributed to the popularity of this 
medication [10]. Despite investigations into other spinally administered local anes-
thetics, these three local anesthetics (i.e., chloroprocaine, lidocaine, and tetracaine) 
would find widespread use for short duration, moderate duration, and long duration 
operative procedures for the next half of a century. Shortly after the approval of 
chloroprocaine, mepivacaine (1956) [11] and prilocaine (1965) [12] would see their 
first usage in spinal anesthesia. These two medications, both xylidine derivatives as 
well, demonstrate similar potency when compared to lidocaine [9]. With subsequent 
studies demonstrating a risk for the development of transient neurologic symptoms 
associated with intrathecal lidocaine administration, it would seem that mepivacaine 
and prilocaine are currently undergoing further investigation and may serve as 
alternatives to lidocaine for ambulatory or surgical procedures of short to moderate 
duration [13–15]. The mid-1960s discovery, synthesis, and spinal administration 
of bupivacaine, an intermediate to long-acting amide local anesthetic, resulted in 
widespread popular clinical application [16, 17]. When evidence surfaced regarding 
the potential for racemic bupivacaine toxicity, two (S)-enantiomers of bupivacaine 
were researched and scrutinized for spinal anesthesia administration. Initial studies 
utilizing spinal ropivacaine (S-enantiomer of bupivacaine) were conducted in the 
early 1990s [18–20]. Additional studies regarding the other pure (S)-enantiomer of 
bupivacaine, levobupivacaine, were initiated in 1999 [21–23]. Intrathecal adminis-
tration of both levobupivacaine and ropivacaine continue.
Table 1. 
Local anesthetics for spinal anesthesia.
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2.2.2 Pharmacokinetics of intrathecal local anesthetic administration
The exact mechanism and site of action of local anesthetics in the intrathecal 
space are not clear. Some evidence suggest that local anesthetics work to directly 
inhibit Na+ and K+ ion channel conduction at the peripheral dorsal nerve root and the 
spinal cord within the thecal sac [9, 24]. For this to occur, the local anesthetic must be 
absorbed by the neuron and bind to an intracellular site on the Na+/K+ ion channels. 
This may only occur when the channels are seen in a conformation associated with 
depolarization. Thus, the activity of local anesthetics is referred to as “use-dependent” 
activity [25, 26]. Understandably, there are a minimum number of axonal Na+/K+ 
channels which must depolarize to continue the propagation of the neuronal impulse. 
The term “conduction safety” has been utilized to refer to the overabundance of sum-
mation action potential necessary at the axonal regional level to facilitate continued 
propagation of this impulse. Due to the decreased conduction safety at the telodendron 
of the axon, as compared to the trunk, it is believed that the local anesthetic blockade 
has a greater effect in this region [27]. Recognizing the complexity of the neuro-
physiology of pain, this view of an isolated Na+/K+ channel mechanism may be too 
simplistic [24]. Primary, secondary, and tertiary synaptic activity occurs as sensory 
input is transmitted from the peripheral nervous system to the central nervous system 
and ultimately to the primary sensory cortex of the brain. It is widely recognized that 
neuronal transmission relies on both excitatory and inhibitory post-synaptic potentials 
for inter-neuronal transmission. Liu et al. summarized the current understanding of 
the research, which considers a multitude of potential sites for the activity of spinally 
administered local anesthetics, to include neuronal transmission at the level of the 
dorsal and anterior horn of the spinal cord [9]. It has been postulated that there may 
be a role for calcium ion channel manipulation (low voltage and high voltage L-type 
calcium channels) in this region [28]. Furthermore, it has been proposed that local 
anesthetics administered in the intrathecal space may contribute to the inhibition of 
substance P activity at the level of the dorsal root ganglion and the dorsal horn of the 
spinal cord [29]. Local anesthetics may also contribute to γ-aminobutyric acid inhibi-
tory potentiation resulting in the inhibition of sensory transmission [30].
Even more fascinating is the discussion and research regarding alteration in elec-
trical “coding” by disruption or alteration in “after-potentials” or “after-oscillations.” 
This begins with interruption in neuronal transmission by an incomplete local 
anesthetic neuronal blockade due to sub-blocking concentrations of local anesthetic. 
Inhibition of sequential firing, or the depolarization of specific neurons, or disrup-
tion of weighted telodendron discharge patterns on a single neuron may contribute 
to changes in temporal excitability patterns sufficient to disrupt sensory input [27].
The extent of clinical activity depends upon several pharmacokinetic fac-
tors which can modify the overall visible clinical effects of the local anesthetic. 
By report, there are over 25 different factors, some theoretical, which can affect 
the spread and distribution of local anesthetics within the neuraxis [31]. Patient 
characteristics include age, height, intra-abdominal pressure, patient position, 
CSF currents, and CSF volume. Local anesthetic characteristics include potency, 
dosage, baricity, lipid solubility, degree of protein binding, and the log of the acid 
dissociation constant (i.e., the pKa). These local anesthetic characteristics further 
determine the amount of local anesthetic absorption (neuronal, myelin, adipose, or 
vasculature) and will ultimately contribute to the observed clinical effect.
2.2.2.1 Cerebrospinal fluid
The intrathecal route of local anesthetic administration is unique in that it bypasses 
first pass metabolism by the liver and mechanically penetrates the blood-brain 
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barrier. This deposition into the cerebrospinal fluid generates unique pharmacokinetic 
considerations. As Greene et al. states, “Uptake of local anesthetic injected into the 
CSF determines which neuronal functions are affected, elimination from the CSF 
determines the duration, and distribution within the CSF determines the extent of 
altered neuronal function” [31]. A discussion of CSF is therefore critical.
Cerebrospinal fluid is maintained within the ventricular system of the brain, to 
include the cisterns and the intracranial subarachnoid space, as well as the spinal 
subarachnoid space (i.e., the thecal sac). There is approximately 150 ml of cerebro-
spinal fluid in the healthy, adult patient. CSF is continuously produced by the cho-
roid plexus, and absorbed via arachnoid villi, at a rate of ~20 ml/h with 400–600 ml 
of CSF generated daily [32]. Decreased CSF volume at the time of injection increases 
the concentration of local anesthetic in the administered region and influences the 
clinical effect. Conditions which increase intra-abdominal pressure, and redistribute 
CSF, will mimic CSF volume depletion (i.e., obesity, pregnancy, etc.), amplify CSF 
oscillation, and potentially modify the effects of the local anesthetic as well [33].
2.2.2.2  Absorption, mechanism, onset and duration of action of spinal local 
anesthetics
The uptake or absorption of local anesthetic into the vasculature also limits 
the distribution and clinical effects of spinal anesthesia. As vascular absorption is 
greatest in the epidural space, and the meninges are permeable to local anesthetic, a 
concentration gradient is established between the spinal cord, intrathecal  
space, and the epidural space [34]. While there is little intrathecal vascular absorp-
tion, some local anesthetic may penetrate the pia mater and be absorbed by vascula-
ture in the spinal cord directly. It is also believed that a more efficient mechanism is 
vascular absorption via the increased surface area in the perivascular space (where 
blood vessels perforate the pia mater) [24, 34]. Of additional interest is consider-
ation of the effects that local anesthetics have on spinal vasculature. Bupivacaine 
and ropivacaine have been shown to decrease spinal blood flow, whereas tetracaine 
and lidocaine have been shown to increase spinal blood flow [35, 36].
With regard to absorption, local anesthetic must be in an electrically neutral 
configuration (i.e., as an uncharged hydrophobic form of the medication) to 
penetrate neuronal tissue. This concept necessitates further discussion of acid 
dissociation. Becker and Reed provide a summary for reference [37]. In order to 
maintain stability in solution, local anesthetics are formulated as a hydrochloride 
salt creating a quaternary amine formulation that is electrically charged to enable 
water solubility (hydrophilic). The local anesthetic must, therefore, revert to the 
uncharged lipophilic (hydrophobic) tertiary amine form for neuronal penetration 
(i.e., the electrically neutral form). The more a local anesthetic dissociates and 
releases hydrogen ions at the body’s physiologically neutral pH of 7.4, the more local 
anesthetic will remain in the tertiary form and the greater the neuronal absorption 
(Figure 4). Understanding the resting pH of the medication is useful, as is under-
standing hydrogen ion dissociation. The dissociation equilibrium between hydrogen 
ions and the deprotonated local anesthetic constitutes the equilibrium that deter-
mines the Ka (acid dissociation constant) of the drug. It is expressed as a ratio of 
hydrogen ion dissociation at equilibrium by the following equation:
  K a =  
 [B] [H+]  _
BH+
 (1)
Ka values are typically very small (i.e., 1 × 10
−3), making comparison and 
manipulation more challenging. However, the inverse logarithmic value of the 
Ka can be utilized to express pKa. These pKa values represent the log of the Ka 
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(acid dissociation constant), or the pH at which 50% of the drug is in the proton-
ated electrically charged hydrophilic quaternary amine form, and 50% is in the 
uncharged, lipophilic tertiary amine form. Values range from 7.6 ➔ ~9.0, meaning 
that no local anesthetics reach complete equilibrium within the body’s normal pH 
range of 7.35–7.45. The pKa values for mepivacaine (~7.6), prilocaine (~7.9) and 
lidocaine (~7.9) most closely approximate physiologic pH, suggesting that their 
neuronal absorption occurs more quickly, leading to faster onset of clinical symp-
toms. The pKa values of bupivacaine (~8.1) and ropivacaine (~8.1) have a somewhat 
slower onset of clinical effect [37].
In addition to neuronal and vascular absorption, the lipid absorption of a local 
anesthetic also plays a role in the time of onset—the greater the lipid solubility, the 
faster the myelin/neuronal penetration. As reported by Becker and Reed, however, 
this appears only to be true in vitro. They hypothesize that the higher lipid solubility 
“may impede dispersion throughout tissue fluids.” When applied in vivo, the lipid 
solubility appears to promote adipose tissue absorption over neuronal absorption 
leading to a delayed onset of clinical effect [37]. This helps to explain the clinically 
observed pharmacologic effects of long-acting local anesthetics (i.e., bupivacaine/
ropivacaine/tetracaine) versus shorter-acting local anesthetics such as lidocaine 
and mepivacaine. Lidocaine and mepivacaine have a much faster onset of action 
compared to bupivacaine and ropivacaine when administered intrathecally (despite 
the increased lipid solubility of bupivacaine/ropivacaine).
The pharmacokinetic variable that appears to have the greatest influence on 
the duration of action is the degree of intrathecal protein binding. Clement et al. 
demonstrated that the non-protein bound or unbound fraction of intrathecal bupi-
vacaine is lower than lidocaine. Because bupivacaine has a higher degree of protein 
binding, it has a longer observed clinical effect [38].
2.2.3 Pharmacodynamics of intrathecal local anesthetic administration
The nature of the surgical procedure, or site of pain origination, will dictate 
pursuit of a specific distribution of anesthesia. The distributed effect of intrathe-
cal local anesthetic administration is often measured via perceived differences in 
sensation of temperature or sharp tactile stimulation. Each spinal nerve provides a 
specific anatomic distribution of sensation, or dermatome, which may be measured. 
In addition to the desired clinical sensory blockade, pharmacodynamic effects may 
be seen throughout several organ systems to include the cardiovascular, respiratory, 
gastrointestinal, renal, and immune systems.
Figure 4. 
Mechanism of action of local anesthetics—this file is licensed under the Creative Commons Attribution-Share 
Alike 3.0 Unported license. https://commons.wikimedia.org/wiki/File:LA_andNaV.svg.
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2.2.3.1 Cardiovascular
Undoubtedly, the spinal administration of local anesthesia can result in hypo-
tension. This is largely believed to be secondary to a sympathetic nervous system 
blockade in the region of the pre-ganglionic neuron prior to its synapse on the sym-
pathetic chain ganglion. This blockade results in vascular dilation, which produces a 
decrease in systemic vascular resistance (SVR) (venous > arterial). This decrease in 
SVR, and the associated decrease in preload, may stimulate a reflexive baroreceptor 
response increasing the heart rate to maintain cardiac output. However, it has been 
well reported that patients may also experience a different type of cardiac reflex 
known as the Reverse Bainbridge (atrial), or Bezold-Jarisch reflex (ventricular). 
These reflexes stem from the recognition of a decreased preload to either the atria 
or ventricle, which results in reflexive bradycardia to slow the heart and allow for 
increased filling time. This ultimately results in a lower cardiac output.
Additionally, the distribution of local anesthetic can block cardiac accelerator fibers 
which stem from thoracic sympathetic ganglia T1-T4, further preventing the reflexive 
cardiac baroreceptor response. Due to the complexity of these interacting variables, 
changes to cardiac output with spinal anesthesia are also variable. Ultimately, spinal 
anesthesia often results in a decrease in mean arterial pressure (MAP), though this is 
not necessarily true for pre-eclamptic patients with non-sympathetically mediated 
elevations in blood pressure. When untreated, depressed cardiovascular effects may 
result in decreased cerebral perfusion, nausea/vomiting, and cardiovascular collapse.
2.2.3.2 Respiratory
In 1991, Steinbrook et al. investigated the effects of spinal lidocaine and bupivacaine 
on resting pulmonary function in eleven volunteers. They identified a slight decrease in 
end-tidal CO2 (34 mmHg ➔ 31 mmHg) with an inverse age correlation (i.e., younger 
patients had a greater drop in end-tidal CO2). They reported the absence of significant 
change in tidal volume, respiratory rate, and minute ventilation, hypothesizing instead 
an increase in dead space ventilation associated with spinal administration. They fur-
ther comment on the paralysis of abdominal musculature leading to an increase in chest 
wall compliance and a decrease in mechanical work of breathing. It is interesting to 
note their comments regarding increased chest wall compliance and increased respira-
tory frequency variation [39]. Of note, they also allude to spinal level deafferentation of 
the chest wall receptors, but make no specific reference to intercostal involvement.
2.2.3.3 Renal
It is well recognized that the kidney receives direct sympathetic innervation 
from renal sympathetic nerve fibers derived from the sympathetic chain ganglia. In 
addition, the kidney auto-regulates its blood flow utilizing humoral/endocrine fac-
tors released as a result of changes sensed in the macula densa. It is believed that this 
mechanism functions both interdependently and independently from sympathetic 
function, enabling the preservation of renal blood flow in the absence of sympa-
thetic directive. As described by Smith et al. [40], “It is possible to assume that the 
renal vascular bed acquires autonomy de novo only as a consequence of denerva-
tion, but in view of the rapidity and smoothness of anesthetic denervation any such 
assumption seems quite superfluous.” It is now understood that there is little effect 
on overall renal function as a result of spinal or epidural sympathetic blockade from 
local anesthetic administration. Glomerular filtration and renal blood flow are 
recognized to only decrease slightly in direct relation to decreases in mean arterial 
pressure associated with the sympathetic blockade [40–42].
Local Anesthetics
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2.2.3.4 Digestive
Sympathetic nervous system blockade as a consequence of spinal local anesthetic 
administration leads to unimpeded parasympathetic nervous system activity and 
gastrointestinal hyperactivity. Hypotension encountered as a result of spinal local 
anesthesia may lead to gastrointestinal ischemia and the release of emetogenic sub-
stances such as serotonin. Furthermore, hypotension may lead to hypoperfusion of 
the area postrema of the medulla (brain stem—known chemoreceptor trigger zone 
for vomiting) resulting in increased serotonin release. The combination of these 
factors may contribute to intraoperative/postoperative nausea and vomiting. It is 
also important to recognize that hypotension associated with spinal local anesthetic 
administration may result in hypoperfusion of the liver. Because hepatic blood 
flow is not auto-regulated, this low perfusion pressure may result in impairment of 
metabolic functions to include subsequent drug metabolism [43].
2.2.3.5 Immune
Regarding the anti-inflammatory and immunomodulatory effects of local anes-
thetics, Cassuto et al. wrote that it is well recognized that the innate and adaptive 
immune systems contribute to the destruction of foreign substances and tissue repair 
following injury. The immune cells involved in these processes include neutrophils, 
macrophages, monocytes, mast cells, T-cells, and B-cells. These cells must undergo 
chemotactic targeting to the area of injury, adhere to blood vessel walls, traverse the 
blood vessel wall into the tissue, engulf the offending agent, and destroy it. Local 
anesthetics have been thought to interfere with every step of this process. They inhibit 
leukocyte adherence to the vascular endothelium by possibly interrupting interactions 
between leukocyte cell membrane integrins and their receptors (cellular adhesion 
molecules—CAMs) expressed on the vascular endothelium. Similarly, they inhibit 
the trans-endothelial migration and motility of leukocytes and may interfere with 
the “priming” of leukocytes, preventing their full pathogen-destroying capability by 
decreasing their free radical production. It has been suggested that local anesthetics 
further interrupt the normal cellular actomyosin filament activity resulting in disrup-
tion of the ability of the leukocyte to modulate the cell membrane to engulf the offend-
ing agent for lysosomal destruction. Furthermore, local anesthetics are responsible for 
a dose-dependent decrease in the release of lysosomal enzymes [44, 45].
Of additional interest are the anti-inflammatory properties of local anesthetics 
that are believed to stem from their inhibition of arachidonic acid derivative synthesis, 
their release of histamine, and their attenuation of cytokine release (i.e., IL-1, IL-6, 
IL-8, TNF-alpha, etc.). Inhibition of phospholipase A2 synthesis prevents arachidonic 
acid cleavage; inhibition of prostaglandin E1/E2 synthesis has been attributed to a 
potential reduction in inflammatory pain; inhibition of thromboxane A2 synthesis 
results in decreased platelet aggregation; and inhibition of leukotriene B4 synthesis 
has been implicated in the reduction of capillary hyper-permeability, resulting in 
decreased edema formation due to inflammatory plasma extravasation. Based on 
this aggregate model of cell membrane interference (i.e., ion channel inhibition, cell 
membrane protein cleavage, cell membrane receptor binding and inhibition, cell 
membrane actomyosin function disruption, etc.) researchers have targeted investiga-
tion of specific local anesthetics for their antibacterial and antiviral effects [44, 46].
2.2.3.6 Factors which effect intrathecal spread
Several factors are considered relevant to the intrathecal spread of local anes-
thetic. These factors may be divided into three categories: factors specific to the 
11
Current Local Anesthetic Applications in Regional Anesthesia
DOI: http://dx.doi.org/10.5772/intechopen.88528
local anesthetic solution, factors specific to the patient, and factors specific to the 
procedure itself. All of these have been described in an article by Hocking and 
Wildsmith which may be referenced for additional information [47].
With regard to the local anesthetic solution, the degree of intrathecal spread is 
related to the baricity, temperature, viscosity, and dosage of local anesthetic admin-
istered. Baricity is the ratio of substance density to CSF density. As such, there are 
hyperbaric, hypobaric or isobaric (i.e., denser than cerebrospinal fluid, less dense 
than cerebrospinal fluid, or similar density to cerebrospinal fluid) formulations of 
local anesthetic solution. Upon injection, baricity affects the caudal versus cephalad 
spread of solution within the CSF. Baricity, in combination with patient position-
ing, will ultimately determine the spread and distribution of local anesthetic within 
the thecal sac. Temperature also affects the density of a local anesthetic solution 
such that a refrigerated or warmed solution may possess a baricity different from its 
manufactured specification. Investigations evaluating the additional effect of local 
anesthetic solution viscosity on intrathecal spread suggest that increased viscosity is 
associated with increased local anesthetic distribution within the intrathecal space 
[48]. Finally, there is a relationship between dosage, volume, and concentration. 
Recognizably, changes in any of these variables influence the others as they pertain 
to the specific mixture of a local anesthetic solution prepared for administration. 
Though several studies have been performed to evaluate these factors, dosage seems 
to have the most significant impact on the intrathecal spread of local anesthetic.
In discussing patient factors, patient height, position, and age all contribute 
to the spread of intrathecal local anesthetic. Though it may affect spread, gross 
height is not a reliable characteristic for determination of local anesthetic dosing. 
Hartwell et al. demonstrated a correlation between vertebral column length and 
the level of local anesthetic sensory blockade. As a surrogate for height, the authors 
suggest the use of vertebral column length instead. This recommendation is based 
on the recognition that there may be patient height differences attributed to differ-
ences in extremity length, which have no reference value with regard to thecal sac 
dimensions or cerebrospinal fluid volume. Regarding thecal sac characteristics, it 
is recognized that the vertebral column curvatures (and thus variations in thecal 
sac positioning) influence the intrathecal spread of local anesthetic. The interplay 
between lumbar lordosis, thoracic kyphosis, and baricity helps to explain the 
largely “dependent” thoracic distribution of hyperbaric local anesthetic solutions 
after intrathecal injection and positioning of a patient in the supine position. With 
regard to baricity, it was demonstrated that the density of CSF varies between 
patients. CSF in women is less dense than in men. It is less dense in pregnant women 
than in non-pregnant women and is less dense in pre-menopausal women than 
in post-menopausal women. This fact has unique importance in that a significant 
portion of surgeries performed under spinal anesthesia are cesarean sections in pre-
menopausal, pregnant women who can be expected to have decreased CSF density. 
It has been further demonstrated that extremes of age can impact the spread of 
intrathecal local anesthetic. Veering et al. reported on the increasing length of time 
required for the maximum upper level of analgesia to be seen with advancing age. 
This was associated with an inverse onset of motor blockade relationship such that a 
faster onset of motor blockade was seen with advancing age. Furthermore, the time 
to peak plasma concentration of local anesthetic was increased, and the total plasma 
clearance decreased with advancing age [49–52].
Finally, procedural components may have an impact on the distribution of local 
anesthetic. It is known that the initial pressure generated by the injection of local 
anesthetic creates waves within the CSF. It was previously believed that generation of 
additional fluid waves, via a technique known as barbotage, would facilitate greater 
spread. Several investigations have demonstrated that barbotage does not affect the 
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ultimate height of the sensory blockade. It may, however, slightly decrease the time to 
achieve maximum sensory and motor blockade, though this may be of limited clinical 
value [53–55]. Regarding injection speed and pressure itself, studies have been mixed. 
It would seem that utilizing increasing speed, and pressure of injection potentially 
facilitates a greater spread of isobaric local anesthetic with diminishing effects seen 
with hyperbaric local anesthetic [47, 56]. Lastly, the needle orientation and approach 
(midline versus paramedian) to the neuraxis may alter local anesthetic distribution. 
James et al. demonstrated a faster onset of T4 block when the Sprotte needle was 
inserted with the side eye facing cephalad [57]. Urmey et al., similar to Neigh et al., 
also reported a higher dermatomal distribution when the side aperture of the needle 
was oriented in a cephalad manner [58, 59]. To the contrary, Masse et al. reported that 
the orientation of the aperture of the Whitacre needle did not influence the cephalad 
spread of hyperbaric bupivacaine in parturients [60]. Stienstra et al. demonstrated 
that a paramedian approach with steep angle (70–100 degrees from level) was also 
associated with a greater cephalad sensory blockade [61].
2.2.4 Adverse effects
2.2.4.1 Local anesthetic systemic toxicity
Each local anesthetic has a unique pharmacokinetic profile. This profile dictates 
the potential for adverse events that may be seen with local anesthetic administra-
tion. One of the most concerning adverse effects is local anesthetic systemic toxicity 
(LAST). Inadvertent vascular administration or changes in vascular absorption 
may result in a constellation of symptoms, dependent upon the rate of increase in 
serum concentration and the injection location. Symptoms are typically classified 
into two groups: central nervous system or cardiovascular. Central nervous system 
(CNS) symptoms may include dizziness, perioral numbness, tinnitus, metallic 
taste, agitation, seizures, and coma. Cardiovascular (CV) symptoms, usually seen 
with increasing serum concentrations, may include dysrhythmias (i.e., tachycardia, 
bradycardia, and ventricular ectopy), myocardial depression, hypotension, and 
asystole. It is important to note, however, that CNS symptoms may not be noted 
prior to the onset of cardiovascular collapse. The potential for local anesthetic 
toxicity may be conceptualized using a metric estimation of the ratio of CV toxic 
dose: CNS toxic dose. This ratio is lower (i.e., more potential for cardiac toxicity) 
for amide anesthetics such as ropivacaine and bupivacaine (with bupivacaine 
having the lowest ratio and greatest potential for toxicity). This is due in part to 
its lipid solubility, greater protein binding, and hepatic metabolism [62, 63]. An 
exact mechanism for LAST has yet to be fully elucidated, but it has been suggested 
that the ultimate cause is likely a combination of Na+/K+/Ca2+ ion channel blockade 
(resulting in myocardial depression) in conjunction with metabotropic intracellular 
effects. These intracellular effects include a potential mitochondrial translocase 
inhibition, which may prevent the movement of the acyl portion of fats and ketones 
into the inner mitochondria for energy processing. This substrate reduction may 
create a synergistic depression of cardiac function as a consequence of the myocar-
dial reliance on mitochondrial oxidation of fatty acids and ketones for energy [63].
It is important to recognize that certain pathophysiologic states will also affect the 
toxicity of local anesthetics. These include renal dysfunction, cardiac dysfunction, and 
hepatic dysfunction. In patients with renal dysfunction, a greater volume of distribu-
tion and greater alpha-1 glycoprotein binding would portend a lower free fraction 
serum concentration. However, there is often a hyperdynamic circulation associated 
with diminished elimination of the agent leading to a variable serum concentration 
and recommendations for reduced dosages [63]. Patients with severe heart failure 
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experience a decreased intravascular uptake portending a lower serum concentration. 
However, they often experience diminished renal and hepatic perfusion leading to 
a decreased rate of metabolism and elimination necessitating recommendations for 
reduced dosages as well. Finally, severe hepatic disease, with its associated decreased 
hepatic metabolism, necessitates decreased local anesthetic administration to offset 
the delayed metabolism and elimination of the local anesthetic from the body [63].
Regardless of the manifestation, the key to successful treatment is early consider-
ation of the diagnosis. The development and widespread distribution of lipid emulsion 
has improved the survival of such cases via a mechanism that includes a combination 
of reduced tissue binding and improved energetic-metabolic effects. Since the first 
report of a patient saved by lipid rescue in 2006 [64] case reports and clinical experi-
ence have continued to add to the body of evidence suggesting its efficacy.
2.2.4.2 Neurotoxicity
Initial concerns regarding the administration of lidocaine for spinal anesthesia 
surfaced in the early 1990s. At that time, microcatheters were being employed for the 
continuous intrathecal administration of lidocaine. A case report in 1991 brought to 
light the potential for cauda equina syndrome associated with intrathecal lidocaine 
administration. This was believed to be a result of pooling of high concentration (5%) 
lidocaine inside the caudal dural sac [65]. Ongoing surveillance and reporting, how-
ever, indicated a continuum of symptoms. This was described at the time as Transient 
Radicular Irritation (TRI) associated with intrathecal bolus lidocaine administration 
for spinal anesthesia. These symptoms were later reclassified and have come to be 
better known as Transient Neurologic Symptoms (i.e., the occurrence of sensory 
radicular neuropathic pain in the absence of motor dysfunction that resolves within 
72 h) [66]. Additional studies were performed to evaluate for contributing causes 
to include concentration, baricity, dosage, and adjuncts (i.e., epinephrine, dextrose, 
etc.). Furthermore, the occurrence of TNS with alternative local anesthetics, such as 
bupivacaine, mepivacaine, etc., have been investigated as well.
2.2.4.2.1 Reported incidence of neurotoxicity
According to data presented by Brull et al., the incidence of radiculopathy or neu-
ropathy following contemporary spinal local anesthetic administration is believed to 
occur in 3.78 out of 10,000 spinal esthetics. They further report that the risk of cauda 
equina syndrome with spinal anesthesia is less frequent, occurring in ~0.11/10,000, 
and the risk of permanent neurologic injury is reportedly exceedingly rare [67].
2.2.4.2.2 Neurotoxicity mechanism
The exact mechanism for the occurrence of neurologic injury or production of 
transient neurologic symptoms is unknown. Recognizably, each local anesthetic has 
a different pharmacodynamic profile resulting in greater frequency (i.e., lidocaine) 
versus lesser frequency (i.e., bupivacaine) of neurologic symptoms believed to be 
secondary to neuronal insult. There has been a suggestion that neurologic symp-
toms following spinal local anesthetic administration may stem from the local 
vasoconstrictive properties of the local anesthetic [68]. It is understood that differ-
ent local anesthetics have different vasoconstrictive effects and that these effects 
are also dose-dependent. High concentrations of local anesthetic result in vasodila-
tion, whereas low concentrations have a more vasoconstrictive effect [68]. This 
vasoconstrictive effect at low dose may result in neuronal ischemia. Certainly, there 
is always the potential for mechanical trauma from the needle or intrafascicular 
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injection with increased intrafascicular administration pressures leading to neu-
ronal ischemia and injury [65]. This, however, is rare. There is research that sug-
gests the effects of local anesthetics are the result of their impact on intracellular 
metabolism, such as on the mitogen-activated protein kinase (MAPK) and caspase 
pathways. It is interesting to note the activation of different MAPK pathways with 
specific local anesthetics (i.e., tetracaine activates the c-Jun N-terminal kinase 
pathway versus lidocaine activation of the p38 MAPK pathway) [69]. Furthermore, 
use of lipoxygenase inhibitors seems to diminish the degree of neuronal apoptosis 
in response to lidocaine administration suggesting a potential role for inflammatory 
mediators in the generation of neurotoxicity [69]. Kan et al. further investigated 
an inflammatory component by demonstrating the ability to regulate levels of 
caspase-9 and matrix-metalloprotease-3 expression via preemptive incubation 
with subsequent inflammatory signaling pathway modification. This resulted in 
decreased apoptosis in response to in vitro neuronal lidocaine administration [70].
2.2.4.3 Other adverse effects
2.2.4.3.1 Hypotension
Hypotension after spinal local anesthetic administration is a well-known direct 
effect of sympathetic nervous system blockade with venous pooling of blood in the 
lower extremities. Defining hypotension is as challenging as determining treatment 
since the literature utilizes different definitions (i.e. <100 mmHg, <90 mmHg, <80% of 
baseline, etc.) [71]. Numerous studies have evaluated different methodologies for treat-
ing this hypotension. Definition and treatment are beyond the scope of this chapter.
2.2.4.3.2 Infectious complications
Historically, and anecdotally, spinal local anesthetic administration has a low 
reported incidence of infectious complications, and include, but are not limited to 
paraspinal abscesses, spinal/epidural abscesses, meningitis, arachnoiditis, and sys-
temic inflammation with sepsis. In reviewing the literature for infectious complica-
tions, a very low correlating incidence was discovered. Moore and Bridenbaugh, after 
reviewing 52,112 spinal anesthetics, reported the occurrence of three central nervous 
system infections (i.e., 0.06 cases per 1000) [72]. In a more recent review, Horlocker 
et al. reported on the occurrence of two infectious complications out of 4767 consecu-
tive spinal anesthetics which were reviewed (i.e., 0.4 cases per 1000). One case was a 
disc abscess and the other a paraspinal abscess. Both patients remained neurologically 
intact after appropriate treatment. Infections associated with spinal local anesthetic 
injection are infrequent and, as discussed previously, may be due in part to the 
concentration-dependent antibacterial effects of local anesthetic administration [73].
2.2.4.3.3 Vertebral canal hematoma
The etiology of vertebral canal hematoma after neuraxial local anesthetic 
administration appears multifactorial with patient-related (i.e., demographics, 
comorbidities, etc.), medication-related and procedural contributions [74]. Historical 
demographic data portrays a potential predisposition based upon age and gender [75]. 
The retrospectively reported incidence of vertebral canal hematoma varies widely 
and ranges from 1:3600 (seen in patients receiving a spinal local anesthetic for total 
knee arthroplasty), to 1:200,000 (as seen in obstetric patients receiving an epidural 
local anesthetic for labor analgesia) [74, 76, 77]. The report on the Third National 
Audit Project of the Royal College of Anesthetists further suggests a prospective 
15
Current Local Anesthetic Applications in Regional Anesthesia
DOI: http://dx.doi.org/10.5772/intechopen.88528
incidence of 8 vertebral canal hematomas in 707,425 (~ 1:88,000). Interestingly, 
46% of these neuraxial blocks were spinals, and there were zero vertebral canal 
hematomas associated with spinal instrumentation. Recognizably, this complication 
portends a notably poor prognosis associated with persistent neurologic deficit [78].
2.2.4.3.4 Thermoregulatory disruption
Administration of spinal anesthesia is associated with a disruption in thermo-
regulation. The threshold for vasoconstriction and shivering in response to hypo-
thermia becomes dysregulated. According to Kurz et al., the threshold for triggering 
a thermoregulatory response to hypothermia is decreased by ~0.5°C. Temperature 
is lost more quickly during the initial 30 min after spinal anesthesia (as a result 
of core-to-peripheral redistribution of heat) when compared to epidural local 
anesthetic administration. This is believed to be secondary to a lesser degree of 
autonomic thermal dysregulation in the lower extremities with epidural local 
anesthesia administration (i.e., failure to obtain a complete blockade with epidural 
versus spinal local anesthesia administration). This clinical effect garners greater 
importance when considering the detrimental effects of hypothermia (i.e., wound 
infection, coagulopathy, delayed arousal from anesthesia, etc.). Though beyond the 
scope of this chapter, yet still of clinical importance, is the potential additive effect 
of intrathecal opioid administration on the disruptive thermoregulatory effect of 
spinal local anesthetic administration [79–81].
2.2.4.3.5 Post-dural puncture headache
The term post-dural puncture headache often refers to a clinical constellation 
of symptoms seen after penetration of the dura mater. Symptoms include the 
presence of a transient, self-limited, positional, frontal-occipital headache tradi-
tionally believed to occur within 72 h of dural penetration. In addition, patients 
may complain of nausea (+/− vomiting), dizziness, tinnitus, neck stiffness, or 
photophobia. Studies indicate a significant association with specific types of needles 
used for spinal local anesthetic administration. Smaller gauge, pencil point needles 
(i.e., spinal needles) are less often associated with post-dural puncture headaches, 
as compared to larger gauge cutting needles (i.e., epidural needles). For this reason, 
post-dural puncture headache is less often associated with spinal local anesthetic 
administration, as compared to inadvertent puncture with epidural catheter place-
ment. Historically, treatments focused on bed rest, hydration, caffeine, and analge-
sics to include acetaminophen and NSAIDs. These conservative treatments are not 
currently supported by evidence of efficacy. The sterile epidural injection of blood 
(i.e., an epidural blood patch), is recognized as traditional therapy and is effective 
in providing adequate pain relief in ~65–70% of patients. Optimally, in light of the 
challenges with treating post-dural puncture headaches, it is best to avoid inadver-
tent dural puncture. If inadvertent dural puncture occurs, techniques to minimize 
the likelihood of post-dural puncture headache should be considered [82].
2.2.4.3.6 Hearing loss
Hearing loss after neuraxial local anesthetic administration deserves special 
consideration. Some providers remain unaware of the potential for this type of 
transient, self-limited low-frequency sensorineural hearing loss. This type of 
hearing loss may be as prevalent as 10–50% of all spinal local anesthetic administra-
tions (with such variable reported prevalence due to the limited degree of patient/
clinician awareness). Interestingly, it seems the same risk factors for a post-dural 
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puncture headache apply in the setting of post-spinal local anesthesia hearing loss. 
According to Sprung et al., the subarachnoid space is contiguous with a small canal 
in the ear (i.e., the cochlear aqueduct) that transmits cerebrospinal fluid pressure 
to the inner ear. Sound waves are theorized to be transmitted through the fluid 
in the middle ear onto the basilar membrane. Changes in transmitted pressure to 
the middle ear are hypothesized to distort the interpretation of these sound waves 
through the basilar membrane. Decreases in cerebrospinal fluid pressure, as trans-
mitted through the cochlear canal and into the fluid of the inner ear, is believed to 
be the mechanism by which patients suffer a loss of low-frequency sensorineural 
hearing after spinal anesthesia administration [83].
2.3 Epidural administration
2.3.1 Contents and structure of the epidural space
Transitioning to a discussion of epidural local anesthetic administration gener-
ates an opportunity for a brief discussion of the epidural anatomy to supplement 
the anatomy discussed at the beginning of the chapter.
2.3.1.1 Definition/surrounding bony construct
The epidural space is widest posteriorly in the midline and averages about 5 mm 
between the ligamentum flavum and the dura in the lumbar region. The boundaries 
of the epidural space are:
Above: the foramen magnum where the periosteal and spinal layers of the 
dura fuse
Below: the sacrococcygeal membrane
Anteriorly: the posterior longitudinal ligament covering the posterior aspect of 
the vertebral bodies and the intervertebral discs
Posteriorly: the anterior surfaces of the vertebral lamina and the ligamentum flavum
Laterally: the pedicles of the vertebrae and the intervertebral foramina [1, 84]
Interestingly, spinal nerve root cuffs are identified along the lateral aspect of the 
epidural space. These have previously been defined as “prolongations of the dura 
and arachnoid lamina” and are believed to enclose spinal nerve roots within this 
space. Previously referred to as “dural cuffs,” it is now believed that the cuffs include 
not only the dura mater but the arachnoid mater as well, thus making this previous 
term inaccurate [85]. This construct may influence the spread of local anesthetic 
when administered via the epidural route.
2.3.1.2 Adipose tissue
The contents of the spinal canal are cushioned in a packing of fat, through which 
injected solutions track while spreading to target receptors. This adipose tissue is richly 
vascularized [86, 87] yet lies mostly unattached in the spinal canal. In the region of 
nerve roots, collagen concentration increases and coalesces with the fat in the interver-
tebral foramina. Adipose tissue “competes” for its share of the drug, along with nervous 
tissue and vasculature, and is an important pharmacologic space and repository. 
Medications with high lipid solubility and/or lipoprotein binding tend to enter and 
remain in this tissue, depending on local blood flow, and can impact drug behavior in 
the epidural space profoundly. This competition with extraneural tissue then generates, 
when compared to spinal doses, a higher epidural medication dosage requirement [88].
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2.3.1.3 Vasculature
Spinal arteries, epidural veins, and lymphatics are all co-inhabitors of this 
space. Spinal arteries derive from the vertebral, ascending cervical, deep cervical, 
intercostal, lumbar, and iliolumbar arteries. They lie chiefly in the lateral epidural 
space. Epidural veins arise from the internal vertebral venous plexus and drain 
both the spinal cord and the spinal canal. Lying mainly anterolaterally, they pass 
through the intervertebral foramina on their journey toward the vertebral, posterior 
intercostal, lumbar and lateral sacral veins. It is through this network that increased 
pressures (intra-abdominal and intrathoracic) are transmitted to the epidural space 
[84]. The lack of valves in this system results in the distention of these vessels and a 
consequent reduction in epidural space volume. The lymphatic network is located 
anteriorly to the intervertebral foramen and aid in the cleansing of the subarach-
noid space, draining to the regional lymph nodes.
2.3.1.4 Rivulets
The interrelationship between the factors that influence epidural blockade and 
the clinical effect is surprisingly complex. Epidural analgesia is not a simple matter of 
spinal root or ganglion blockade, but rather is the end state of action at various sites 
after passage through multiple sites. Unique to epidural local anesthetic administra-
tion is the concept of rivulets. Hogan reported the spread of injected ink as “rivulets” 
through numerous small channels rather than as a unified advancing front [89]. 
Injection results in circumferential spread anteriorly and posteriorly around the thecal 
sac. Laterally, epidural solution extrudes beyond the intervertebral foramen following 
a parallel path along the paraspinous musculature fascial plane [89]. Hogan et al. also 
noted that the lateral spread of epidural solution sporadically encompassed the more 
proximal dorsal nerve root prior to the dorsal root ganglion in the “axilla” of the nerve 
root. This non-uniform distribution of solution, within the epidural space, may then 
correlate with clinical data suggesting that slow, not fast, injection rates (0.3–0.75 ml/s) 
result in the most effective spread of analgesia [89]. Undoubtedly, this variation in 
epidural space content combined with varying spread contributes to the somewhat 
unpredictable clinical effects seen with epidural local anesthetic administration.
2.3.2 Pharmacokinetics of epidural local anesthetic administration
2.3.2.1 Factors which affect epidural spread
As mentioned above, and contrary to the effects of intrathecal local anesthetic, 
the complex nature of epidural analgesia is suggested by the lack of relevance of 
physical factors affecting anatomical spread when compared to the clinically pres-
ent segmental analgesia.
2.3.2.2 Absorption, potency, duration, onset
Local anesthetics stabilize excitable cell membranes and block sodium and 
potassium flux through the axonal membrane ion pores. The anesthetic profile and 
clinical characteristics of a local anesthetic depends on its lipid solubility, protein 
binding, and dissociation constant (pKa). Lipid solubility is generally agreed to 
be the primary determinant of intrinsic anesthetic potency. Protein binding is the 
characteristic associated with duration of action of the agent since those that attach 
to protein components of nerve membranes are less likely to diffuse from the site of 
action to enter the systemic circulation. The pKa of a compound, as discussed earlier 
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in detail and defined as the pH at which there is equilibrium between the ionized 
and unionized states of the molecule, impacts the rate of onset of clinical effect. 
This value is important for effective anesthesia because the uncharged form of 
the molecule is essential for epineural diffusion across lipid nerve sheaths and cell 
membranes. Conversely, only the charged form can dissociate in water and diffuse 
through cellular fluid and intracellular metabolism [90, 91].
2.3.2.3 Metabolism
The metabolic mechanism of local anesthetics depends on their chemical 
classification. Amide-type local anesthetics, including ropivacaine, are primarily 
metabolized by the hepatic esterase activity seen in the P450 system in the liver [92, 
93]. Ester-type local anesthetics (procaine, benzocaine, tetracaine) are predomi-
nantly hydrolyzed by plasma pseudocholinesterase.
2.3.3 Pharmacodynamics of epidural local anesthetic administration
2.3.3.1 Measuring effects
A discussion of clinical effect should include a comment on the differential 
blockade. Independent of differences in nerve fiber size and resistance to blockade, 
local anesthetics have varied differential blockade characteristics. Even within a single 
agent, the differential blockade can vary. As an example, bupivacaine, one of the best 
agents at producing effective analgesia while sparing motor loss, loses its motor-spar-
ing characteristics as the bupivacaine concentration is increased from 0.5 to 0.75%.
The mode of action of epidural analgesia is far from clear. Proposed sites of action 
have included: (1) mixed spinal nerves in the paravertebral space, (2) dorsal root ganglia, 
(3) spinal roots, and (4) the periphery of the spinal cord. Regardless, blockade of a nerve 
fiber varies based on the duration of exposure, the exposed length of the axon, the type 
and site of the axon, and the concentration of local anesthetic at the axonal membrane.
Tachyphylaxis describes the condition of acute tolerance to local anesthetic drugs, 
though its mechanism is not well understood. The relationship between the change 
of response and interval between injections is complicated. However, it is likely the 
interval between the disappearance of analgesia and the subsequently repeated injec-
tion of local anesthetic is primary. When it occurs, decreasing analgesic effectiveness 
is noted, including a decrease in the number of dermatomes blocked as well as a 
decrease in motor block, showing that all measurable components of anesthesia are 
affected. Simply, with repeated doses, fewer segments are anesthetized, the duration 
of action is decreased, and both motor and sensory blockade are less intense [94].
The response to epidural blockade includes both autonomic blockade as a result 
of sympathetic interruption and somatic pain blockade (similar to intrathecal 
injection of local anesthetic, but with a greater duration of time to achieve clinical 
effect). The sympathetic blockade has consequent effects on vascular beds, cardiac 
functioning, and other visceral structures as discussed previously. Somatic pain 
blockade provides for the potential of anatomic functional restoration secondary 
to pain responses. Both results can occur as a consequence of epidural blockade and 
may be utilized in the operating room, in the labor suite or the pain clinic.
3. Conclusions
In conclusion, the administration of local anesthetic via the intrathecal or epidural 
route possesses unique pharmacokinetic and pharmacodynamic properties. These 
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properties are influenced by the complex anatomy of bones, ligaments, membranes, 
vasculature, and adipose tissue. Understandably, the mechanism of action of local anes-
thetics is complex with primary Na+ and K+ ion channel activity. Additional involve-
ment of Ca2+ ion channels, γ-aminobutyric acid, and substance P have been proposed.
Pharmacokinetic variables affecting the clinical picture associated with local 
anesthetic administration include the protein binding, lipid solubility, and pKa. Spinal 
local anesthetic pharmacodynamic effects are variable and influenced by factors 
that are unique to the local anesthetic solution, factors that are unique to the patient, 
and factors that are associated with the method of local anesthetic administra-
tion. Epidural pharmacodynamic effects are characterized by a lack of relevance of 
physical factors affecting anatomical spread when compared to the clinically present 
segmental analgesia. Both spinal and epidural local anesthetic administration are 
associated with clinical effects that involve the cardiovascular, pulmonary, digestive, 
renal, and immune systems to varying degrees of significance. Local anesthetic toxic-
ity affects the nervous system and cardiovascular system to varying degrees based on 
the properties of the individual local anesthetic (i.e., lipid solubility, CV: CNS toxicity 
ratio, etc.) and the toxic dosage administered. Regardless of the manifestations of 
toxicity, the key to successful treatment is early consideration of the diagnosis. The 
development and widespread distribution of lipid emulsion has improved survival 
and should be considered in all cases where local anesthetic toxicity is a concern.
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